Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Review of Complement Activation in SLE.
Weinstein A, Alexander RV, Zack DJ. Weinstein A, et al. Among authors: alexander rv. Curr Rheumatol Rep. 2021 Feb 10;23(3):16. doi: 10.1007/s11926-021-00984-1. Curr Rheumatol Rep. 2021. PMID: 33569681 Free PMC article. Review.
Cell-bound complement activation products in SLE.
Ramsey-Goldman R, Li J, Dervieux T, Alexander RV. Ramsey-Goldman R, et al. Among authors: alexander rv. Lupus Sci Med. 2017 Aug 21;4(1):e000236. doi: 10.1136/lupus-2017-000236. eCollection 2017. Lupus Sci Med. 2017. PMID: 29214038 Free PMC article. Review.
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.
Ramsey-Goldman R, Alexander RV, Massarotti EM, Wallace DJ, Narain S, Arriens C, Collins CE, Saxena A, Putterman C, Kalunian KC, O'Malley T, Dervieux T, Weinstein A. Ramsey-Goldman R, et al. Among authors: alexander rv. Arthritis Rheumatol. 2020 Jan;72(1):78-88. doi: 10.1002/art.41093. Epub 2019 Nov 25. Arthritis Rheumatol. 2020. PMID: 31469249 Free PMC article.
Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE.
Wallace DJ, Alexander RV, O'Malley T, Khosroshahi A, Hojjati M, Loupasakis K, Alper J, Sherrer Y, Fondal M, Kataria R, Powell T, Ibarra C, Narain S, Massarotti E, Weinstein A, Dervieux T. Wallace DJ, et al. Among authors: alexander rv. Lupus Sci Med. 2019 Sep 19;6(1):e000349. doi: 10.1136/lupus-2019-000349. eCollection 2019. Lupus Sci Med. 2019. PMID: 31592328 Free PMC article.
Cell-bound complement activation products associate with lupus severity in SLE.
Arriens C, Alexander RV, Narain S, Saxena A, Collins CE, Wallace DJ, Massarotti E, Conklin J, Kalunian KC, Putterman C, Ramsey-Goldman R, Buyon JP, Askanase A, Furie RA, James JA, Bello GA, Manzi S, Ahearn J, O'Malley T, Weinstein A, Dervieux T. Arriens C, et al. Among authors: alexander rv. Lupus Sci Med. 2020 Apr;7(1):e000377. doi: 10.1136/lupus-2019-000377. Lupus Sci Med. 2020. PMID: 32371480 Free PMC article.
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified Lupus.
Ramsey-Goldman R, Alexander RV, Conklin J, Arriens C, Narain S, Massarotti EM, Wallace DJ, Collins CE, Saxena A, Putterman C, Brady K, Kalunian KC, Weinstein A. Ramsey-Goldman R, et al. Among authors: alexander rv. ACR Open Rheumatol. 2021 Feb;3(2):116-123. doi: 10.1002/acr2.11219. Epub 2021 Feb 4. ACR Open Rheumatol. 2021. PMID: 33538130 Free PMC article.
16 results